U.S. News & World Report14d
David Altschuler
What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
The Associated Press on MSN12d
FDA approves painkiller designed to eliminate risks of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often ...
WSLS 1013d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
a key factor is working to block pain signaling before it gets to the brain,” Vertex’s Dr. David Altshuler, told The Associated Press last year. Commonly reported side effects with the drug ...
HealthDay on MSN7d
FDA Approves First New Non-Opioid Pain Pill in Decades
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
CBS News12d
FDA OK's painkiller designed to end opioids' addiction and overdose risk
"In trying to develop medicines that don't have the addictive risks of opioid medicines, a key factor is working to block pain signaling before it gets to the brain," Vertex's Dr. David Altshuler ...
Medical Xpress12d
FDA approves first new non-opioid pain pill in decades
"In trying to develop medicines that don't have the addictive risks of opioid medicines, a key factor is working to block pain signaling before it gets to the brain," Dr. David Altshuler ...
Voice of America12d
FDA approves painkiller designed to eliminate risk of addiction
"In trying to develop medicines that don't have the addictive risks of opioid medicines, a key factor is working to block pain signaling before it gets to the brain," Vertex's Dr. David Altshuler ...